Key Points - The global power battery installation reached 285.1 GWh from January to April 2025, with a year-on-year growth of 36% driven by the sales of 5.39 million new energy vehicles, which increased by 29% [3] - China's power battery installation accounted for 60.9% of the global total, with six out of the top ten companies being Chinese, and the highest growth rate of 68% was observed in Honeycomb Energy [3] - The global installation of lithium iron phosphate power batteries saw a year-on-year increase of 63%, primarily due to the sustained growth in China's lithium iron phosphate battery installations [3] Company Developments - Ruite New Materials announced that its solid-state battery electrolyte materials have begun sales, although the revenue contribution remains small, and further development is needed in technology and commercial routes [6] - Haitian Energy announced the mass production of the world's first 1175Ah long-duration energy storage battery, marking a new phase for large-scale applications in long-duration energy storage [8] - Zhengli New Energy's 25 GWh automotive power lithium battery project is set to commence production in the fourth quarter of 2025, with a total investment of 10 billion yuan [10] - Tianshi Materials signed an investment agreement to build a comprehensive production base for electrolytes and key raw materials in Morocco, with an expected annual output of 150,000 tons and a total investment of approximately 2.8 million USD [15] Industry Collaborations - Talan New Energy and Nandu Power signed a cooperation agreement to integrate Talan's Safe+ solutions with Nandu's energy storage system technology, aiming to establish a new safety benchmark in the energy storage industry [13] - EcoPro BM from South Korea announced the suspension of its CAD 1.2 billion (approximately 630 million yuan) battery materials factory construction project in Quebec, Canada, due to uncertainties in the electric vehicle and battery industry, particularly influenced by U.S. tariff policies [17]

会议预告 第十八届高工锂电产业峰会 ——产业链格局重整 全场景应用共振 2025高工新能源新材料产业大会 —— AI+新材料 引领能源变革 会议地点： 中国成都邛崃 分技术路线看， 三元电池在 5月呈现 复苏 迹象，其 13.1%的环比增速，结束了连续七个月的负 增长，并显著超过了磷酸铁锂电池3.9%的增速。 然而，行业的整体集中度正趋于分散。 今年前五个月， CR3电池企业市场份额合计为73%，较 去年同期下降4.8个百分点。 分析指出， 磷酸铁锂电池 因其成本优势而获得高比重渗透，这在客观上减小了产品技术的差异 性，为其他 电池 厂商提供了追赶空间。 份额数据 波动最大的领域来自新能源商用车 市场。 1-5月数据显示，宁德时代在该领域的市场 份额，较去年同期下滑超过10个百分点，退守至50%的水位线。 受此影响，宁德时代今年前五个月在国内的整体市场份额，也较去年同期下滑了 3个百分点。 主办单位： 高工锂电、高工产业研究院（GGII） 会议时间： 2025年6月25-26日 会议地点： 常州·金坛万豪酒店 中国动力电池市场 5月份延续增长，但数据显示，行业头部企业的增长正在放缓，市场竞争格局随 之出现新的 ...

Core Viewpoint - EVE Energy plans to issue H shares and list in Hong Kong, expanding the A+H listing model alongside CATL and BYD, indicating a strong trend of Chinese lithium battery companies entering the Hong Kong market [1][3][24] Group 1: International Expansion - EVE Energy aims to enhance its international brand image and competitiveness through this listing, aligning with its global strategy [3] - The company has established a global cooperation operating model (CLS) to reduce investment risks in overseas markets, collaborating with firms like Daimler Trucks and Cummins [6][7] - EVE Energy is rapidly expanding its overseas production capacity, with factories in Hungary and Malaysia, targeting significant production outputs to support major clients like BMW [8][9][10] Group 2: Hong Kong Listing Trend - The trend of lithium battery companies listing in Hong Kong is gaining momentum, with several firms transitioning from A-share markets to seek opportunities in Hong Kong [12][22] - April 2023 saw a surge in Hong Kong listing announcements from various companies, reflecting strong interest from international capital in the renewable energy sector [13][19] - The market capitalization of the Hong Kong renewable energy sector has significantly increased, from $125 billion a decade ago to $568 billion by March 2023, indicating robust growth potential [20] Group 3: Market Dynamics - The shift to Hong Kong listings is partly due to the tightening of IPOs in the A-share market, with companies seeking more favorable conditions in Hong Kong [22][23] - EVE Energy's position as a leading player in the industry makes its entry into the Hong Kong market a strategic move to attract international capital [24] - The competitive landscape for Chinese battery companies is expected to intensify globally, as they seek to establish market shares and customer bases across different continents [25]

今年4月，苏州资本市场迎来"高光时刻"。正力新能、映恩生物-B、众捷汽车（301560）三家来自不同 领域的企业相继登陆港交所、深交所创业板，总募资额超29.6亿元，凸显出苏州作为全国产业创新前沿 阵地的蓬勃动能和多元包容的资本市场生态。 2025年开年，苏州已新增境内外上市公司6家，资本市场"苏州板块"上市公司总数超270家，稳居全国前 列，科创板企业数量全国第三——这一发展成果离不开苏州雄厚的产业基础、完备的政策保障以及高效 的上市服务生态体系。 苏州市委金融办副主任张礼贤在接受证券时报记者采访时介绍称，上市公司是开放创新的排头兵，也是 经济高质量发展的重要引擎。苏州坚持打造以科技型中小企业、民营科技企业为基础，高新技术企业、 瞪羚企业为主体，独角兽企业、科技上市企业为标杆的创新型企业梯队，并抢抓科创板政策机遇，建立 起金融、产业、科技部门联动的发现和培育机制。对于已上市企业，苏州将全面推进"参天计划"，引导 企业以上市为起点，用好资本市场融资工具加快战略布局，成长为昂首挺立的参天大树。 "苏州板块"亮出科创名片 4月25日，众捷汽车在深交所创业板挂牌上市。至此，苏州有超270家企业登陆境内外资本市场，上 ...

Core Viewpoint - Heng Rui Pharmaceutical successfully listed on the Hong Kong Stock Exchange on May 23, 2023, achieving a market capitalization exceeding HKD 390 billion, marking the largest pharmaceutical IPO of the year [4][5]. Company Overview - Heng Rui Pharmaceutical's IPO price was set at HKD 44.05, with the stock opening nearly 30% higher [4]. - The cornerstone investors for this IPO included notable entities such as the Government of Singapore Investment Corporation (GIC), Invesco, UBS Global Asset Management, Hillhouse Capital, and Boyu Capital, with total subscriptions exceeding HKD 4.1 billion [4]. - The company was founded by Sun Piaoyang, who transformed a small pharmaceutical factory into a major player in the Chinese pharmaceutical industry [6][7]. Financial Performance - For the first three quarters of 2024, Heng Rui reported revenues of CNY 20.19 billion and a net profit of CNY 4.62 billion, with net profit reaching a historical high [11]. - The sales revenue from innovative drugs accounted for 47.7% of total revenue, indicating a significant contribution from generic drugs [11]. - The proportion of innovative drug sales increased from 38.1% in 2022 to 43.4% in 2023 [11]. Strategic Direction - The company aims to enhance its global presence through the Hong Kong listing, which is seen as a bridge for international expansion and brand recognition [12]. - The funds raised from the IPO will be used to build new production and R&D facilities both domestically and internationally [12]. Market Context - The Hong Kong stock market has seen a surge in IPO activity in 2023, with significant listings such as Ningde Times and Mixue Ice City, contributing to a total fundraising amount exceeding HKD 60 billion, a sixfold increase compared to the previous year [18]. - The current market environment is favorable for new listings, with a substantial pipeline of around 150 applications under review at the Hong Kong Stock Exchange [18][19].

| 健倍苗苗(02161) | 2.380 | 2.380 | 0.42% | | --- | --- | --- | --- | | 中视金桥(00623) | 2.710 | 2.750 | 0.36% | | 古茗(01364) | 26.600 | 27.550 | 0.36% | | ＴＣＬ电子(01070) | 11.000 | 11.220 | 0.36% | | 建设银行(00939) | 6.970 | 7.000 | 0.29% | | 中国移动(00941) | 88.100 | 88.450 | 0.23% | | ＧＸ日本全球领导 | 70.160 | 70.160 | 0.20% | | (03150) | | | | | ＧＸ０３月债(03440) | 55.360 | 55.360 | 0.18% | | 港灯－ＳＳ(02638) | 5.650 | 5.670 | 0.18% | | 安硕亚洲除日(03010) | 59.880 | 60.100 | 0.17% | | ESR(01821) | 12.840 | 12.840 | 0.16% | | ＧＸＡＩ基础设施 | 5 ...

Core Insights - In April 2025, a total of 24 Chinese companies successfully completed IPOs across A-shares, Hong Kong, and US markets, raising a total of 14.6 billion yuan, with a significant increase in the number of IPOs compared to the previous year [6][10][30]. Group 1: IPO Market Overview - The number of IPOs in April 2025 increased by 50% year-on-year, while the total fundraising amount rose by 152% compared to the same month last year [10][11]. - The top five companies by fundraising amount were Tianyouwei, Bawang Chaji, Ying'en Biotechnology, Zhengli New Energy, and Taihong Wanli [8][10]. - The A-share market returned to a normal state, while the Hong Kong A+H track remained active, and the number of Chinese companies going public in the US reached a one-year high [11][30]. Group 2: Market Breakdown - In April 2025, the A-share market saw 10 companies go public, with a total fundraising of 8.3 billion yuan, while the Hong Kong market had 2 IPOs raising 2.5 billion yuan [22][27]. - The US market had 12 Chinese companies listed, raising a total of 3.8 billion yuan, marking a significant increase in both the number of IPOs and the amount raised compared to the previous year [30]. Group 3: Performance Metrics - The first-day drop rate for IPOs was 16.67%, with 4 out of 24 companies experiencing a decline on their debut [16]. - The highest first-day gain was recorded by Huatuo Securities, which surged by 396.25%, while Tianci International faced the largest drop at 35% [17][18]. Group 4: Industry and Regional Analysis - The automotive and transportation sector led in fundraising, totaling 4.973 billion yuan, accounting for 34.06% of the total [54][59]. - Jiangsu province topped the fundraising chart with 3.982 billion yuan, followed by Heilongjiang and Beijing [62][67]. Group 5: VC/PE Exit Analysis - In April 2025, 12 companies with VC/PE backing went public, achieving a total exit return of 27.9 billion yuan, with an average return multiple of 9.11 times [37][43]. - The consumer sector had the highest exit return, with Bawang Chaji generating a return of 10.516 billion yuan and a multiple of 80.03 times [41][37].

从IPO企业融资来看，今年以来，港股23家IPO上市企业中，12家企业IPO融资额超7亿港元，10家企业 IPO融资额超10亿港元，6家企业IPO融资额超20亿港元，IPO融资额前三名分别为宁德时代、蜜雪集 团、赤峰黄金，IPO融资额分别为356.57亿港元、39.73亿港元、32.45亿港元。此外，南山铝业国际、古 茗、布鲁可、映恩生物、宜宾银行、钧达股份、绿茶集团、正力新能等公司IPO融资额均超10亿港元。 今年以来，港股IPO市场持续火爆，借助宁德时代IPO募资357亿港元，港股IPO募资额跃居全球第一。 据Wind资讯数据统计，今年1月1日至5月20日，港股共有23家企业IPO，较去年同期增加6家；IPO融资 规模达600亿港元，较去年同期增长626.54%，IPO融资规模重回全球首位。 新消费+科技类公司占IPO主流 从IPO行业分布来看，今年以来，港股IPO公司主要来自电气设备、消费者服务、有色金属、医药生 物、银行、高科技等行业，新消费+科技类公司占主流。其中电气设备、消费者服务、有色金属行业募 资位居前三名，募资额分别达372.96亿港元、68.51亿港元、56.23亿港元。此外，医药生物、耐 ...

Group 1: Company Overview - Contemporary Amperex Technology Co., Limited (CATL) has successfully listed in Hong Kong, raising HKD 35.657 billion, making it the largest IPO in the Hong Kong market since Kuaishou [1] - CATL's IPO could potentially become the largest globally by 2025 if the over-allotment option is exercised, raising the total to HKD 41 billion [1] Group 2: Market Dynamics - The innovative drug sector is currently experiencing significant growth, with companies like 3SBio seeing stock price increases of over 60% in recent trading days, driven by positive market sentiment [1] - The global market for Type 2 diabetes (T2DM) and obesity treatments is projected to grow significantly, with T2DM expected to reach USD 106.2 billion and obesity USD 58.5 billion by 2032, reflecting compound annual growth rates of 4.9% and 22.9% respectively [9] Group 3: Company Specifics - Paig Biological - Paig Biological, a biotechnology company focused on chronic disease therapies, is currently in the process of an IPO in Hong Kong, with a subscription period from May 19 to May 22, 2025 [2][5] - The company has undergone multiple rounds of financing, with a post-money valuation of approximately CNY 4 billion as of June 2023 [4] Group 4: Product Pipeline and Competition - Paig Biological's core product, PB-119, is a GLP-1 receptor agonist aimed at treating T2DM and obesity, with its NDA for T2DM accepted by the National Medical Products Administration in September 2023 [9][10] - The competitive landscape for PB-119 is challenging, with 13 competitors in the T2DM space and over 15 in the obesity treatment sector, including established players like Novo Nordisk and Eli Lilly [10] Group 5: Financial Performance - Paig Biological has reported net losses of CNY 306 million, CNY 279 million, and CNY 283 million for the years 2022, 2023, and 2024 respectively, alongside significant R&D expenditures [11]

Investment Rating - The report maintains a "Positive" outlook on the solid-state battery industry, highlighting its potential as a next-generation battery technology with significant attention from the entire industry chain [4][9]. Core Viewpoints - Solid-state batteries face dual challenges of process and cost, but recent advancements indicate a consensus on mass production by 2027, with key players in the automotive and battery sectors actively releasing products [9][12]. - The manufacturing of solid-state batteries requires a comprehensive reconstruction of equipment and processes due to fundamental differences in material compatibility and bonding logic compared to liquid lithium-ion batteries [21][22]. - Equipment development is crucial for achieving scale production and cost reduction, with dry processing techniques being identified as effective methods for lowering costs and improving efficiency [22][34]. Summary by Sections Industry Overview - The solid-state battery industry is gaining traction, with a clear direction and trend towards mass production by 2027, driven by collaboration across the supply chain [4][9]. Manufacturing Challenges - The transition from laboratory to mass production faces significant technical challenges, particularly in scaling up cell sizes from the current average of 20Ah to the required 60Ah for automotive applications [12][21]. - Key challenges include the stability of material systems, consistency of processes, and safety of systems, all of which impact yield rates, production efficiency, and costs [12][21]. Equipment and Process Innovations - The report emphasizes the need for innovative equipment and processes, particularly in the areas of solid electrolyte film production and interface engineering, to address the unique requirements of solid-state batteries [21][35]. - Dry processing techniques are highlighted as essential for the production of solid-state batteries, offering advantages in efficiency and environmental impact [22][34]. Investment Recommendations - The report suggests focusing on companies that are closely collaborating with clients and have secured orders or achieved delivery in the key equipment sector, such as Naconor (832522), Honggong Technology (301662), and others [4][9].